The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

DelveInsight's, “Oncolytic Virus Cancer Therapy Pipeline Insight, 2025,” report provides comprehensive insights about 120+ ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

A new study finds that prior herpesvirus infections are linked to a faster age-related increase in blood biomarkers ...

State lawmakers unsuccessfully attempted to extend the law this year to cover the intentional exposure of other sexually ...

Genital Herpes Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The report provides a detailed analysis of the current genital herpes marketed drugs ...

Suck blisters, or chafed lips, are very common in breastfeeding babies. However, this doesn't mean they're normal. Read on to ...

Anti-NMDA Receptor Encephalitis is a rare brain condition that can be mistaken for the flu or a psychiatric illness Here’s ...

Hailey Riches perdeu a filha Violet com apenas 30 dias de vida após uma infecção devastadora por herpes. Agora, ela ...

Meredith R. Klifto, MD, is an assistant professor of ophthalmology at the University of North Carolina School of Medicine, ...